Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. - Wikidata - awgldk - TriplyDB

Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.

Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.

http://www.wikidata.org/entity/Q35179454

about

An emerging treatment option for glaucoma: Rho kinase inhibitors Systemic and Ocular Hemodynamic Risk Factors in Glaucoma Achieving Target Pressures with Combined Surgery: Primary Patchless Ahmed Valve Combined with Phacoemulsification vs Primary Phacotrabeculectomy.Correlation between biomechanical responses of posterior sclera and IOP elevations during micro intraocular volume change Visual field improvement in the collaborative initial glaucoma treatment study.Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015 Anti-scarring effects of butaprost on human subconjunctival Tenon's fibroblasts Intraocular pressure magnitude and variability as predictors of rates of structural change in non-human primate experimental glaucoma.Instability of 24-hour intraocular pressure fluctuation in healthy young subjects: a prospective, cross-sectional study Intraocular pressure-lowering efficacy and safety of bimatoprost 0.03% therapy for primary open-angle glaucoma and ocular hypertension patients in China.Why Do People (Still) Go Blind from Glaucoma?Clinical characteristics and current treatment of glaucoma.Incidence and long-term outcomes of the human immunodefıciency virus neuroretinal disorder in patients with AIDS 24-hour IOP telemetry in the nonhuman primate: implant system performance and initial characterization of IOP at multiple timescales.Nocturnal systemic hypotension increases the risk of glaucoma progression.Trabecular micro-bypass shunt (iStent®): basic science, clinical, and future).Diurnal intraocular pressure fluctuation and its risk factors in angle-closure and open-angle glaucoma.A Longitudinal Study of Association between Adiposity Markers and Intraocular Pressure: The Kangbuk Samsung Health Study Relationship between progression of visual field defect and intraocular pressure in primary open-angle glaucoma Circadian rhythm of intraocular pressure in the adult rat The Effect of Diurnal Fluctuation in Intraocular Pressure on the Evaluation of Risk Factors of Progression in Normal Tension Glaucoma The impact of surgical intraocular pressure reduction on visual function using various criteria to define visual field progression.Mechanism of Action of Selective Laser Trabeculoplasty and Predictors of Response.Primary Open-Angle Glaucoma in Individuals of African Descent: A Review of Risk Factors Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS)A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.Influence of BAK-preserved prostaglandin analog treatment on the ocular surface health in patients with newly diagnosed primary open-angle glaucoma.Correlation between short-term and long-term intraocular pressure fluctuation in glaucoma patients.Assessment of choroidal thickness and volume during the water drinking test by swept-source optical coherence tomography Ocular drug delivery for glaucoma management.Primary Baerveldt Shunt Implantation: Outcomes and Complications.Associations of sleep duration with open angle glaucoma in the Korea national health and nutrition examination survey.Genome-wide association study and meta-analysis of intraocular pressure New trends in glaucoma risk, diagnosis & management.Rho-kinase inhibitors offer a new approach in the treatment of glaucoma.Ocular perfusion pressure in glaucoma.Brinzolamide plus brimonidine for the treatment of glaucoma: an update.Clinicians' perspectives on the use of drug-eluting contact lenses for the treatment of glaucoma.Finite element modeling of the viscoelastic responses of the eye during microvolumetric changes.

P2860

Q22305851-A001E576-ECD0-4571-AB2F-352458DA85E1 Q26777829-758B9B22-8ACD-4594-B53B-B2FB31E75A8B Q27687087-210C4B64-4045-4784-AA5C-B72A60B3DA8E Q30439112-DA012CFF-51C2-4580-897E-8F61C25507F6 Q30590721-8D605D07-1AF7-4BCA-B57E-612C6542A1CB Q30749049-C3E1D886-2D27-49DE-89C8-A6CF0EF51109 Q33912443-194837D6-3CD9-4F73-9D26-C639223CE964 Q34409191-A43AA279-6B30-4062-8836-2884E9F09177 Q34515278-3663CFE6-F292-4CDC-8EE2-C0B7076E9865 Q35102806-DFC99A4C-A35C-404F-BFCE-E2F01B13F167 Q35160642-BCC1B57D-1507-447E-B715-1B6BF866D346 Q35180374-AF5ECD00-77CE-4CC4-8A44-668C29DF9D6F Q35214017-74BAC132-2061-46AF-8C03-3C70C854A9F6 Q35247623-7F6F2EBE-68F6-4941-AEDB-8CAD16792B29 Q35282184-7423725E-CA77-4D3A-9EA6-33703D11B504 Q35549740-E009B7C6-FF90-46D2-B740-C36CB9D70DFF Q35840280-1FB4DEB3-EEFE-41F5-8F1D-B6947939BFFB Q35885636-4E0C48CB-6A27-4001-9635-FB1590B1D59F Q35892410-E5D4D1ED-99E9-4FD3-8540-613C315373FE Q36166579-4E1EC4CE-9437-4B4B-9236-86162EC162F9 Q36173205-F51DA9F8-5303-450B-986F-E21FF8BD7185 Q36177048-3363C356-91D5-4B4D-8F1F-9B82A8C47636 Q36298587-A70AD360-85BA-45A9-BB42-BD8C32D1941F Q36351687-4C2590CF-4667-454C-87E6-8BB77BE005C8 Q36718154-7A5D0CCF-A9DA-41E9-A4D5-079EA8D6C1E4 Q36958046-89A69688-01F7-4F17-BC50-62142CB5F3B6 Q36968248-687CF100-C8D6-40B8-98BC-F837684309C4 Q37067698-D6AA8D52-8CF1-41F7-A69B-21C941882668 Q37241919-FA21C95A-02F3-4239-ABDA-4AF678C765AD Q37325071-49F9DF35-794D-4C81-AAC0-034101266A60 Q37327814-E4945379-0780-45F3-92A3-14A00F443219 Q37444726-CDDEA2B6-D333-4CB5-A281-00B762147819 Q37552148-234F196B-A8E7-4A27-8937-ECAACA6BDB9C Q37695742-07AC1EEC-2C8C-423E-B8F5-0C8AD9DD0C19 Q38109064-AFC65909-5659-456B-B142-EAC3B414CA73 Q38149325-51D7C524-E7FB-4BEC-A3AD-E66EDED0C3A9 Q38163108-09D27086-E123-4392-B37E-905B802A2257 Q38255431-30C0D519-47F5-4ACE-A413-9E877C171633 Q38270686-DACDA0DD-96D2-4583-B799-181D27D05AD6 Q38428022-F0C77894-323E-4B0D-B914-7C2F8F6166E8

P2860

Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.

http://www.wikidata.org/entity/Q35179454

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Intraocular pressure control a ...... tial Glaucoma Treatment Study.

@ast

Intraocular pressure control a ...... tial Glaucoma Treatment Study.

@en

type

label

Intraocular pressure control a ...... tial Glaucoma Treatment Study.

@ast

Intraocular pressure control a ...... tial Glaucoma Treatment Study.

@en

prefLabel

Intraocular pressure control a ...... tial Glaucoma Treatment Study.

@ast

Intraocular pressure control a ...... tial Glaucoma Treatment Study.

@en

P1433

Q35179454-5E222B4D-69BF-4FF8-8716-7A05DE3199E2

P1476

Q35179454-C40C4A58-B8EE-4302-AC98-5D9B0C533D8F

P2093

Q35179454-2F3CCD55-AB83-4AC2-B780-5C4E6CF814DC

Q35179454-58EC6ADC-8DF7-43E5-83AE-D2849162357A

Q35179454-A6601784-1D71-4FD3-BED6-4E0596D2A740

Q35179454-A7D57E95-5A35-458E-A88B-05E50607AD3E

Q35179454-AA023F88-52F3-4ADF-A18E-8F64D5F7A742

Q35179454-B0F42869-701D-44D2-963A-B5DA7E453E91

P2860

Q35179454-18C35EC2-F15F-4E01-ABBE-D01C1A5DBA9A

Q35179454-1E94005D-EEC1-4459-BCB8-B3918AF2F51F

Q35179454-2887D982-B3C9-4C05-8AB0-286588A1C078

Q35179454-288E1627-451C-4F4F-8693-D37EDACE6446

Q35179454-2AC59D5A-97C5-458E-B589-3D9F60562ADE

Q35179454-30F517E9-4B0A-43F1-867F-70CEF40A18F1

Q35179454-32A60B56-0F6C-4C36-82ED-D4B52AE576B0

Q35179454-45D49F1B-8E9E-443F-8FAF-2D8E79F17C67

Q35179454-66227A07-B11E-4790-B2F8-9DA9066B0DFF

Q35179454-67F9890A-AA2A-4604-AD8E-A9BC7B2823B4

P304

Q35179454-4ED7D85D-D83F-4C51-A62E-37C57BA68331

P31

Q35179454-1513B493-8D81-40CD-9929-9EC0AAD40CE3

P356

Q35179454-7E50E0AE-0352-4708-83F6-8ED01170D59A

P433

Q35179454-D5189B1A-5971-4DF1-8212-622014BBAB48

P478

Q35179454-A34F1A45-044D-4E33-B6E8-90C55C89B6D0

P577

Q35179454-AFD2E4AC-2721-4492-95AC-ABD1F3A2F942

P5875

Q35179454-D9538F0C-A33B-47F8-84C7-9BB068F0D44B

P698

Q35179454-EAC94EFA-14E7-4C6E-8DEA-B03FA5AC88BA

P921

Q35179454-4D123843-3779-4094-B711-25800F2D9586

P932

Q35179454-F9CCB65E-2A08-48AD-ACC5-3ED565379166

P356

J.OPHTHA.2011.01.047

P1433

P1476

Intraocular pressure control a ...... tial Glaucoma Treatment Study.

@en

P2093

Brenda W Gillespie

http://www.w3.org/2001/XMLSchema#string

CIGTS Study Group

http://www.w3.org/2001/XMLSchema#string

David C Musch

http://www.w3.org/2001/XMLSchema#string

Leslie M Niziol

http://www.w3.org/2001/XMLSchema#string

Paul R Lichter

http://www.w3.org/2001/XMLSchema#string

Rohit Varma

http://www.w3.org/2001/XMLSchema#string

P2860

Random-effects models for longitudinal data

Impact of intraocular pressure regulation on visual fields in open-angle glaucoma.

Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial.

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Association between intraocular pressure variation and glaucoma progression: data from a United States chart review.

The collaborative initial glaucoma treatment study: baseline visual field and test-retest variability.

Predictors of long-term progression in the early manifest glaucoma trial.

Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.

Prevalence of open-angle glaucoma among adults in the United States.

The quality of medical evidence: implications for quality of care.

P304

1766-1773

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.OPHTHA.2011.01.047

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51154292

http://www.w3.org/2001/XMLSchema#string

P698

21600658

http://www.w3.org/2001/XMLSchema#string

P921

P932

3161134

http://www.w3.org/2001/XMLSchema#string